Matrix metalloproteinase-7-dependent release of tumor necrosis factor-α in a model of herniated disc resorption

Journal of Clinical Investigation

Volumn 105, Issue 2, 2000, Pages 143-150

  Haro, Hirotaka ^a,b   Crawford, Howard C ^b   Fingleton, Barbara ^b   Shinomiya, Kenichi ^c   Spengler, Dan M ^a   Matrisian, Lynn M ^b  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MATRILYSIN; STROMELYSIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CARTILAGE CELL; CELL INFILTRATION; CHONDROLYSIS; COCULTURE; CONTROLLED STUDY; INTERVERTEBRAL DISK HERNIA; LOW BACK PAIN; MACROPHAGE MIGRATION; MODEL; MOUSE; NONHUMAN; ORGAN CULTURE; PERITONEUM MACROPHAGE; PRIORITY JOURNAL;

EID: 0033966350     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI7091     Document Type: Article

References (35)

1. Frymoyer, J.W., and Cats-Baril, W.L. 1991. An overview of the incidence and costs of low back pain. Orthop. Clin. North Am. 22:263-271.
2. Wisneski, R.J., Garfin, S.R., and Rothman, R.H. 1992. Lumbar disc disease. In The spine. 3rd. edition. R.H. Rothman and F.A. Simeone, editors. W.B. Saunders Co. Philadelphia, PA. 671 pp.
3. Anderson, G.B.J., and Weinstein, J.N. 1996. Disc herniation. Spine. 21:1S.
4. Frymoyer, J.W. 1988. Back pain and sciatica. N. Engl. J. Med. 318:291-300.
5. Komori, H., et al. 1996. The natural history of herniated nucleus pulposus with radiculopathy. Spine. 21:225-229.
6. Komori, H., et al. 1998. Contrast-enhanced magnetic resonance imaging in conservative management of lumbar disc herniation. Spine. 23:67-73.
7. Haro, H., et al. 1996 Upregulated expression of chemokines in herniated nucleus pulposus resorption. Spine. 21:647-652.
8. Bonassar, L.J., et al. 1995. Changes in cartilage composition and physical properties due to stromelysin degradation. Arthritis Rheum. 38:173-183.
9. Fosang, A.J., et al. 1992. The interglobular domain of cartilage aggrecan is cleaved by PUMP, gelatinases, and cathepsin B. J. Biol. Chem. 267:19470-19474.
10. Kanemoto, M., Hukuda, S., Komiya, Y., Katsuura, A., and Nishioka, J. 1996. Immunohistochemical study of matrix metalloproteinase-3 and tissue inhibitor of metalloproteinase-1 in human intervertebral discs. Spine. 21:1-8.
11. Haro, H., Murakami, S., Komori, H., Okawa, A., and Shinomiya, K. 1997. Chemonucleolysis with human stromelysin-1. Spine. 22:1098-1104.
12. Haro, H., Shinomiya, K., Murakami, S., and Spengler, D.M. 1999. Upregulated expression of matrilysin and neutrophil collagenase in human herniated discs. J. Spinal Disord. 13:245-249.
13. Haro, H., et al. Matrix metalloproteinase-3-dependent generation of a macrophage chemoattractant in a model of herniated disc resorption. J. Clin. Invest. 105:133-141.
14. Mudgett, J.S., et al. 1998. Susceptibility of stromelysin 1-deficient mice to collagen-induced arthritis and cartilage destruction. Arthritis Rheum. 41:110-121.
15. Wilson, C.L., Heppner, K.J., Labosky, P.A., Hogan, B.L.M., and Matrisian, L.M. 1997. Intestinal tumorigenesis is suppressed in mice lacking the metalloproteinase matrilysin. Proc. Natl. Acad. Sci. USA. 94:1402-1407.
16. Laurence, R. 1971. Chemical basis for the histological use of Safranin O in the study of articular cartilage. J Bone Joint Surg. Am. 53:69-82.
17. Matrisian, L.M., et al. 1986. The mRNA coding for the secreted protease transin is expressed more abundantly in malignant than in benign tumors. Proc. Natl. Acad. Sci. USA. 83:9413-9417.
18. Mach, F., Schönbeck, U., Bonnefoy, J.-Y., Pober, J.S., and Libby, P. 1997. Activation of monocyte/macrophage functions related to acute atheroma complication by ligation of CD40: induction of collagenase, stromelysin, and tissue factor. Circulation. 96:396-399.
19. Busiek, D.F., et al. 1992. The matrix metalloproteinase matrilysin (PUMP) is expressed in developing human mononuclear phagocytes. J. Biol. Chem. 267:9087-9092.
20. Nakashima, Y., et al. 1998. Induction of matrix metalloproteinase expression in human macrophages by orthopaedics particulate debris in vitro. J. Bone Joint Surg. Br. 80:694-700.
21. Shapiro, S.D., Kobayashi, D., and Ley, T. 1993. Cloning and characterization of a unique elastolytic metalloproteinase produced by human alveolar macrophages. J. Biol. Chem. 268:23824-23829.
22. Lindy, O., et al. 1997. Matrix metalloproteinase 13 (collagenase 3) in human rheumatoid synovium. Arthritis Rheum. 40:1391-1399.
23. Baumann, H., and Gauldie, J. 1994. The acute phase response. Immunol. Today. 15:74-80.
24. MacNaul, K.L., Chartrain, N., Lark, M.,Tocci, M.J., and Hutchinson, N.I. 1990. Discoordinate expression of stromelysin, collagenase, and tissue inhibitor of metalloproteinases-1 in rheumatoid synovial fibroblasts. Synergistic effects of interleukin-1 and tumor necrosis factor-alpha on stromelysin expression. J. Biol. Chem. 265:17238-17245.
25. Ganu, V.S., et al. 1994. Biochemical and molecular characterization of stromelysin synthesized by human osteoarthritic chondrocytes stimulated with recombinant human interleukin-1. Clin Exp. Rheumatol. 12:489-496.
26. Gearing, A.J.H., et al. 1994. Processing of tumor necrosis factor-alpha precursor by metalloproteinases. Nature. 370:555-557.
27. Shipley, J.M., Wesselscmidt, R.L., Kobayashi, D.K., Ley, T.J., and Shapiro, S.D. 1996. Metalloelastase is required for macrophage-mediated proteolysis and matrix invasion in mice. Proc. Natl. Acad. Sci. USA. 93:3942-3946.
28. Murphy, G., Cockett, M.I., Ward, R.V., and Docherty, A.J.P. 1991. Matrix metalloproteinase degradation of elastin, type IV collagen, and proteoglycan: a quantitative comparison of the activities of 95 kDa and 72 kDa gelatinases, stromelysin-1 and -2 and punctuated metalloproteinase (PUMP). Biochem. J. 277:277-279.
29. Moos, V., Fickert, S., Muller, B., Weber, U., and Sieper, J. 1999. Immunohistological analysis of cytokine expression in human osteoarthritic and healthy cartilage. J. Rheumatol. 26:870-879.
30. Tanabe, B.K., Abe, L.M., Kimura, L.H., Reinker, K.A., and Yamaga, K.M. 1996. Cytokine mRNA repertoire of articular chondrocytes from arthritic patients, infants, and neonatal mice. Rheumatol. Int. 16: 67-76.
31. Black, R.A., et al. 1997. A metalloproteinase disintegrin that releases tumor-necrosis factor-α from cells. Nature. 385:729-733.
32. Moss, M.L., et al. 1997. Cloning of a disintegrin metalloproteinase that processes precursor tumor-necrosis factor-α. Nature. 385:733-736.
33. Powell, W.C., Fingleton, B., Wilson, C.L., Boothby, M., and Matrisian, L.M. 1999. The metalloproteinase matrilysin proteolytically generates active soluble Fas ligand and potentiates epithelial cell apoptosis. Curr. Biol. 9:1441-1447.
34. Suzuki, M., Raab, G., Moses, M.A., Fernandez, C.A. and Klagsbrun, M. 1997. Matrix metalloproteinase-3 releases active heparin-binding EGF-like growth factor by cleavage at a specific juxtamembrane site. J. Biol. Chem. 272:31730-31737.
35. Levi, E., et al. 1996. Matrix metalloproteinase 2 releases active soluble ectodomain of fibroblast growth factor receptor 1. Proc. Natl. Acad. Sci. USA. 93:7069-7074.